Use of total patient data for indirect estimation of reference intervals for 40 clinical chemical analytes in Turkey

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 7, 2006, Pages 867-876

  Iicol, Yesim Ozarda ^a   Aslan, Diler ^b  

^a ULUDAG UNIVERSITY   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Biochemical analytes; Healthy subjects; Indirect reference intervals; Manufacturer suggestions; Modified Bhattacharya procedure; Patient data; Turkish population

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMYLASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; CERULOPLASMIN; CHLORIDE; CHOLESTEROL; CREATINE KINASE; CREATINE KINASE MB; CREATININE; FERRITIN; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LACTATE DEHYDROGENASE; LIOTHYRONINE; LIPOPROTEIN A; MAGNESIUM; PHOSPHORUS; POTASSIUM; PROTEIN; SODIUM; THYROXINE;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CHEMISTRY; CALCIUM BLOOD LEVEL; CERULOPLASMIN BLOOD LEVEL; CHEMOLUMINESCENCE; CHLORIDE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; ENZYME BLOOD LEVEL; FEMALE; FERRITIN BLOOD LEVEL; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOLIC ACID BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; IRON BLOOD LEVEL; LABORATORY TEST; LIOTHYRONINE BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MICROPARTICLE ENZYME IMMUNOASSAY; PATIENT INFORMATION; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY CONTROL; REFERENCE VALUE; SODIUM BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRANSFERRIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC); UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; CHEMISTRY, CLINICAL; CLINICAL CHEMISTRY TESTS; FEMALE; HEALTH; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; TURKEY;

EID: 33745207118     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.139     Document Type: Article

References (48)

1. Solberg HE. Approved recommendation on the theory of reference values: Part 1. The concept of reference values. J Clin Chem Clin Biochem 1987;25:337-42.
2. PetitClerc C, Solberg HE. Approved recommendation on the theory of reference values: Part 2. Selection of individuals for the production of reference values. J Clin Chem Clin Biochem 1987;25:639-44.
3. Solberg HE, PetitClerc C. Approved recommendation on the theory of reference values: Part 3. Preparation of individuals and collection of specimens for the production of reference values. J Clin Chem Clin Biochem 1988;26:593-8.
4. Solberg HE, Stamm D. Approved recommendation on the theory of reference values: Part 4. Control of analytical variation in the production, transfer and application of reference values. Eur J Clin Chem Clin Biochem 1991;29:531-5.
5. Solberg HE. Approved recommendation on the theory of reference values: Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987;25:645-56.
6. Dybkaer R, Solberg HE. Approved recommendation on the theory of reference values: Part 6. Presentation of observed values related to reference values. J Clin Chem Clin Biochem 1987;25:657-62.
7. Grasbeck R. Reference values, why and how. Scand J Clin Lab Invest 1990;S201:45-53.
8. Solberg HE, Grasbeck R. Reference values. Adv Clin Chem 1989;27:2-79.
9. Henny J, PetitClerc C, Fuentes-Arderiu X, Petersen PH, Queralto JM, Schiele F, et al. Need for revisiting the concept of reference values. Clin Chem Lab Med 2000;38:589-95.
10. Horn PS, Pesce AJ. Reference intervals: an update. Clin Chim Acta 2003;334:5-23.
11. Fuentes-Arderiu X, Ferre-Masferrer M, Gonzales-Alba JM, Villarino-Gonzales MI, Arrimadas-Esteban E, Cabrero-Olive D, et al. Multicentric reference values for some quantities measured with Elecsys 2010 analyser. Clin Chim Acta 2001;304:143-6.
12. Back SE, Nilsson JE, Fex G, Jeppson JO, Rosen U, Tryding N, et al. Towards the common reference intervals in clinical chemistry. An attempt at harmonization between three hospital laboratories in Skane, Sweden. Clin Chem Lab Med 1999;37:573-92.
13. Martin HF, Hologgitas JV, Driscoll J, Fanger H, Gudzinowicz BJ. Reference values based on populations accessible to hospitals. In: Gasbeck R, Alström T, editors. Reference values in laboratory medicine. Chichester: Wiley, 1981:233-62.
14. Karisto V, Hanninen KP, Leino A, Pulkki K, Peltola O, Nantö V, et al. Generation of reference values for cardiac enzymes from hospital admission laboratory data. Eur J Clin Chem Clin Biochem 1994;32:789-96.
15. O'Halloran MW, Studley-Ruxton J, Wellby ML. A comparison of conventionally derived normal ranges with those obtained from patient results. Clin Chim Acta 1970;27:35-46.
16. Naus AJ, Borst A, Kuppens PS. Determination of n-dimensional reference ellipsoids using patient data. J Clin Chem Clin Biochem 1982;20:75-80.
17. White JD. Use of patient data in the control of urea, creatinine and electrolyte estimations. Clin Chim Acta 1978;84:353-60.
18. Horn PS, Feng L, Li Y, Pesce AJ. Effect of outliers and non healthy individuals on reference interval estimation. Clin Chem 2001;47:2137-45.
19. Solberg HE. Using a hospitalized population to establish reference intervals: pros and cons [editorial]. Clin Chem 1994;40:2205-6.
20. Schumann G, Klauke R. New IFCC reference procedure for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta 2003;327:69-79.
21. Ilcol YO, Aslan D. Determining reference value of blood chemistry profile in healthy subjects in Bursa. Turk J Biochem 2004;29:183-92 (http://www.turkjbiochem.com).
22. Amador E, Hsi B. Indirect methods for estimating the normal range. Am J Clin Pathol 1969;52:538-46.
23. Richardson RW, Setchell KD, Woodmann DD. Estimation of the normal range for serum cholesterol by different methods. Clin Chim Acta 1972;37:305-8.
24. Bhattacharya CG. A simple method of resolution of a distribution into Gaussian components. Biometrics 1967;23:115-35.
25. Ferre-Masferrer M, Fuentes-Arderiu X, Puchal-Arie R. Indirect reference limits estimated from patients' results by three mathematical procedures. Clin Chim Acta 1999;279:97-105.
26. Gindler EM. Calculation of normal ranges by methods used for resolution of overlapping Gaussian distributions. Clin Chem 1970;16:124-8.
27. Naus AJ, Borst A, Kuppens PS. The use of patient data for calculation of reference values for some haematological parameters. J Clin Chem Clin Biochem 1980;18:621-5.
28. Grossi E, Colombo R, Cavuta S, Franzini C. The RELAB Project: a new method for the formulation of reference intervals based on current data. Clin Chem 2005;51:1232-40.
29. Baadenhuijsen H, Smith JC. Indirect estimation of clinical chemical reference intervals from total hospital patient data: application of a modified Bhattacharya procedure. J Clin Chem Clin Biochem 1985;23:829-39.
30. Oosterhuis WP, Moddderman TA, Pronk C. Reference values: Bhattacharya or the method proposed by the IFCC? Ann Clin Biochem 1990;27:359-65.
31. Faulkner WR, Demers LM. Importance of age-dependent reference intervals in biochemical testing: are we including elderly population? Clin Chem 1994;40:855-6.
32. Kallner A Gustavsson E, Hending E. Can age- and sex-related reference intervals be derived for non-healthy and non-diseased individuals from results of measurements in primary health care? Clin Chem Lab Med 2000;38:633-65.
33. Mahley RW, Palaoglu EK, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, et al. Turkish heart study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995;36:839-59.
34. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001;156:1-10.
35. Bersot TP, Vega GL, Grundy SM, Palaoglu EK, Atagunduz P, Ozbayrakci S, et al. Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J Lipid Res 1999;40:432-8.
36. Mahley RW, Pepin J, Palaoglu EK, Malloy MJ, Kane JP, Bersot TP. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apoprotein E genotype. J Lipid Res 2000;41:1290-301.
37. Bersot TP, Palaoglu EK, Mahley RW. Managing dyslipidemia in Turkey: suggested guidelines for a population characterized by low levels of high density lipoprotein cholesterol. Anadolu Kardiyol Derg 2002;2:321-2.
38. Mahley RW, Can S, Ozbayrakci S, Bersot TP, Tanir S, Palaoglu EK, et al. Modulation of high-density lipoproteins in a population in Istanbul, Turkey, with low levels of high-density lipoproteins. Am J Cardiol 2005;96:547-55.
39. Hodoglugil U, Williamson DW, Huang Y, Mahley RW. An interaction between the Taq IB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks. Clin Genet 2005;68:118-27.
40. Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention. Eur Heart J 1998;19:1434-503.
41. Grover SA, Dorais M, Paradis G, Fodor JG, Frohlich JJ, McPherson R, et al. Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines. Can Med Assoc J 2000;163:1263-9.
42. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 2002;106:3143-421.
43. Stone NJ, Bilek S, Rosenbaum. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustment and options. Am J Cardiol 2005;96(Suppl):53E-9E.
44. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis. Epidemiology, pathophysiology and management. J Am Med Assoc 2002;287:2570-81.
45. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005;28:S4-36.
46. Hubl W, Schmieder J, Gladrow E, Demant T. Reference intervals for thyroid hormones on the Architect analyser. Clin Chem Lab Med 2002;40:165-6.
47. Gonzalez-Sagrado M, Martin-Gil JM. Population-specific reference values for thyroid hormones on the Abbott Architect i2000 analyzer. Clin Chem Lab Med 2004;42:540-2.
48. Dhatt GS, Griffin G, Agarwal MM. Thyroid hormones reference intervals in an ambulatory Arab population on the Abbott Architect i2000 immunoassay analyzer. Clin Chim Acta 2006;364:226-9.